Website
News25/Ratings12
News · 26 weeks93-81%
2025-10-262026-04-19
Mix5590d
- Insider31(56%)
- Other10(18%)
- SEC Filings5(9%)
- Analyst4(7%)
- Earnings3(5%)
- Leadership2(4%)
Latest news
25 items- INSIDERSEC Form 4 filed by Okupe Oluyemi4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERSEC Form 4 filed by Boughton Soleil4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERSEC Form 4 filed by Okupe Oluyemi4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- PRHims & Hers to Announce First Quarter 2026 Financial Results on May 11, 2026Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the leading health and wellness platform, today announced that it will report first quarter 2026 financial results after the market closes on Monday, May 11, 2026. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, referencing conference ID 1704296. A live audio webcast will be available at https://investors.hims.com and will be archived for one year. Upcoming Conference Participation Hims & Hers also announced that members of the company's management
- INSIDERSEC Form 4 filed by Dudum Andrew4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERSEC Form 4 filed by Okupe Oluyemi4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Hims & Hers Health Inc.SCHEDULE 13G/A - Hims & Hers Health, Inc. (0001773751) (Subject)
- PRNovo Nordisk's FDA-Approved GLP-1s Now Available With Hims & HersStarting today, eligible customers can access a broad assortment of treatment options, including the only FDA-approved GLP-1 weight loss pill Hims & Hers Health, Inc. (NYSE:HIMS) today announced that a broad assortment of Novo Nordisk's FDA-approved GLP-1 medications are available to eligible customers, including the Wegovy® pill, which is the only FDA-approved GLP-1 weight loss pill.1 As a part of a collaboration with Novo Nordisk, Hims & Hers is making it simpler for customers to access FDA-approved GLP-1 medications which are now available at more affordable prices, with more doses and delivery methods. This expansion makes Hims & Hers the largest global consumer health platform for af
- INSIDERSEC Form 4 filed by Okupe Oluyemi4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERSEC Form 4 filed by Becklund Irene4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERSEC Form 4 filed by Chi Michael4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERSEC Form 4 filed by Boughton Soleil4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Operating Officer Chi Michael converted options into 72,108 shares and covered exercise/tax liability with 237,756 shares, decreasing direct ownership by 25% to 504,571 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Medical Officer Carroll Patrick Harrison converted options into 16,522 shares and covered exercise/tax liability with 4,022 shares, increasing direct ownership by 7% to 182,440 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERDirector Pendarvis Christiane converted options into 15,211 shares, increasing direct ownership by 42% to 51,774 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Policy Officer Autor Deborah M. converted options into 32,919 shares and covered exercise/tax liability with 11,312 shares, increasing direct ownership by 350% to 27,782 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERPAO Becklund Irene converted options into 17,987 shares and covered exercise/tax liability with 5,832 shares, increasing direct ownership by 572% to 14,281 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Executive Officer Dudum Andrew covered exercise/tax liability with 526,486 shares and converted options into 164,369 shares, decreasing direct ownership by 22% to 1,310,617 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Legal Officer Boughton Soleil covered exercise/tax liability with 168,750 shares and converted options into 41,421 shares, decreasing direct ownership by 29% to 313,643 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Financial Officer Okupe Oluyemi converted options into 105,200 shares and covered exercise/tax liability with 283,990 shares, decreasing direct ownership by 36% to 323,517 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERSEC Form 4 filed by PAO Becklund Irene4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERSEC Form 4 filed by Chief Policy Officer Autor Deborah M.4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERSEC Form 4 filed by Chief Operating Officer Chi Michael4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERSEC Form 4 filed by Chief Medical Officer Carroll Patrick Harrison4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERSEC Form 4 filed by Chief Legal Officer Boughton Soleil4 - Hims & Hers Health, Inc. (0001773751) (Issuer)